A Carbonate, Dilithium CEP of the European Pharmacopoeia monograph is often referred to as a Carbonate, Dilithium Certificate of Suitability (COS). The purpose of a Carbonate, Dilithium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Carbonate, Dilithium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Carbonate, Dilithium to their clients by showing that a Carbonate, Dilithium CEP has been issued for it. The manufacturer submits a Carbonate, Dilithium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Carbonate, Dilithium CEP holder for the record. Additionally, the data presented in the Carbonate, Dilithium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Carbonate, Dilithium DMF.
A Carbonate, Dilithium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Carbonate, Dilithium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Carbonate, Dilithium suppliers with CEP (COS) on PharmaCompass.